These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. From exotic spice to modern drug? Singh S Cell; 2007 Sep; 130(5):765-8. PubMed ID: 17803897 [TBL] [Abstract][Full Text] [Related]
46. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
47. AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders. Geerts H Curr Opin Investig Drugs; 2008 Jul; 9(7):800-11. PubMed ID: 18600585 [TBL] [Abstract][Full Text] [Related]
48. Cancer vaccines: preclinical studies and novel strategies. Palena C; Abrams SI; Schlom J; Hodge JW Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657 [TBL] [Abstract][Full Text] [Related]
49. ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines. Drane D; Gittleson C; Boyle J; Maraskovsky E Expert Rev Vaccines; 2007 Oct; 6(5):761-72. PubMed ID: 17931156 [TBL] [Abstract][Full Text] [Related]
50. Iclaprim, a diaminopyrimidine dihydrofolate reductase inhibitor for the potential treatment of antibiotic-resistant staphylococcal infections. Peppard WJ; Schuenke CD Curr Opin Investig Drugs; 2008 Feb; 9(2):210-25. PubMed ID: 18246524 [TBL] [Abstract][Full Text] [Related]
51. Myelin basic protein administration in multiple sclerosis. Campbell B; Vogel PJ; Fisher E; Lorenz R Arch Neurol; 1973 Jul; 29(1):10-5. PubMed ID: 4123119 [No Abstract] [Full Text] [Related]
52. Pharmacogenomics in the evaluation of efficacy and adverse events during clinical development of vaccines. Nilsson LJ; Regnström KJ Methods Mol Biol; 2008; 448():469-79. PubMed ID: 18370243 [TBL] [Abstract][Full Text] [Related]
53. GI-5005, a yeast vector vaccine expressing an NS3-core fusion protein for chronic HCV infection. Habersetzer F; Baumert TF; Stoll-Keller F Curr Opin Mol Ther; 2009 Aug; 11(4):456-62. PubMed ID: 19649991 [TBL] [Abstract][Full Text] [Related]
54. Dexlansoprazole, a modified release formulation of an enantiomer of lansoprazole, for the treatment of reflux esophagitis. Fock KM; Ang TL Curr Opin Investig Drugs; 2008 Oct; 9(10):1108-15. PubMed ID: 18821474 [TBL] [Abstract][Full Text] [Related]